95% of sponsors & CROs have initiatives in place to address the operational challenges that originated from the rapid adoption o
23 Jan 2023, 13:00
95% of sponsors & CROs have initiatives in place to address the operational challenges that originated from the rapid adoption of decentralised trial methods.
Top priorities include reducing site burden and improving data sharing & collaboration.
Source:
Same news in other sources
2
23 Jan 2023, 13:01
Fact of the day š
95% of sponsors and CROs have initiatives in place to address the operational challenges that originated from the rapid adoption of decentralised trial methods.
Top priorities include reducing site burden and improving data sharing & collaboration.
At Triall, we support the implementation of hybrid and decentralised trials by offering a unified single-point access platform that can be used by sponsors, CROs, sites, and patients.
Source: veeva.com/resources/veeva-digital-clinical-trials-survey-report/
ā”ļø Trade $TRL at bit.ly/tradeTRL
š£ Help us spread the news on Twitter:
#blockchainforhealth #TRL
Fact of the day.
Fact of the day š
95% of sponsors and CROs have initiatives in place to address the operational challenges that originated from the rapid adoption of decentralised trial methods.
Top priorities include reducing site burden and improving data sharing & collaboration.
At Triall, we support the implementation of hybrid and decentralised trials by offering a unified single-point access platform that can be used by sponsors, CROs, sites, and patients.
Source: veeva.com/resources/veeva-digital-clinical-trials-survey-report/
ā”ļø Trade $TRL at bit.ly/tradeTRL
š£ Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1617507441599553538?s=20&t=SK0VBD0Pr8qBDz0bgHBQQg
#blockchainforhealth #TRL
23 Jan 2023, 13:01
Fact of the day š
95% of sponsors and CROs have initiatives in place to address the operational challenges that originated from the rapid adoption of decentralised trial methods.
Top priorities include reducing site burden and improving data sharing & collaboration.
At Triall, we support the implementation of hybrid and decentralised trials by offering a unified single-point access platform that can be used by sponsors, CROs, sites, and patients.
Source: veeva.com/resources/veeva-digital-clinical-trials-survey-report/
ā”ļø Trade $TRL at bit.ly/tradeTRL
š£ Help us spread the news on Twitter:
#blockchainforhealth #TRL
Fact of the day.
Fact of the day š
95% of sponsors and CROs have initiatives in place to address the operational challenges that originated from the rapid adoption of decentralised trial methods.
Top priorities include reducing site burden and improving data sharing & collaboration.
At Triall, we support the implementation of hybrid and decentralised trials by offering a unified single-point access platform that can be used by sponsors, CROs, sites, and patients.
Source: veeva.com/resources/veeva-digital-clinical-trials-survey-report/
ā”ļø Trade $TRL at bit.ly/tradeTRL
š£ Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1617507441599553538?s=20&t=SK0VBD0Pr8qBDz0bgHBQQg
#blockchainforhealth #TRL